Keyphrases
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
100%
Nucleoside Triphosphates
100%
MS Method
100%
Deoxyribonucleoside Triphosphates
80%
Limit of Quantification
40%
Coefficient of Variation
40%
Ribonucleotide Reductase
40%
Within-day
40%
GTI-2040
40%
Clinical Samples
20%
Bone Marrow Samples
20%
Drug Treatment
20%
Antisense
20%
Leukemia Cells
20%
Between-day
20%
Leukemia Cell Lines
20%
Cell Lysate
20%
Cell Samples
20%
K562 Cells
20%
High Performance Liquid Chromatography-tandem Mass Spectrometry (HPLC-MS/MS)
20%
Accuracy Value
20%
MV4-11
20%
Immunology and Microbiology
Liquid Chromatography Mass Spectrometry
100%
Tandem Mass Spectrometry
100%
High Performance Liquid Chromatography
50%
Antisense
50%
Cell Lysate
50%
Leukemia Cell
50%
Leukemia Cell Line
50%
Drug Therapy
50%
Biochemistry, Genetics and Molecular Biology
Tandem Mass Spectrometry
100%
Liquid Chromatography-Mass Spectrometry
100%
Nucleoside Triphosphate
100%
Ribonucleotide Reductase
40%
Cell Lysate
20%
Antisense
20%
Adenosine Triphosphate
20%
High-Performance Liquid Chromatography
20%
K562 Cells
20%
Drug Therapy
20%
Neuroscience
Nucleoside Triphosphate
100%
Liquid Chromatography-Mass Spectrometry
100%
Ribonucleotide Reductase
40%
Adenosine Triphosphate
20%
Cell Line
20%
K562 Cells
20%
Drug Therapy
20%
Food Science
Liquid Chromatography Mass Spectrometry
100%
Tandem Mass Spectrometry
100%
High Performance Liquid Chromatography
50%
Antisense
50%
Pharmacology, Toxicology and Pharmaceutical Science
Nucleoside Triphosphate
100%
Leukemia
40%
Ribonucleotide Reductase
40%
High Performance Liquid Chromatography
20%
Pharmacotherapy
20%
Adenosine Triphosphate
20%